Related Experiment Video
Updated: Jul 13, 2026

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex
Yu Tian1, Robert Kolb, Jeong-Ho Hong
1Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Studies of a TAZ knockout mouse reveal a novel function of the transcriptional regulator TAZ, that is, as a binding partner of the F-box protein beta-Trcp. TAZ-/- mice develop polycystic kidney disease (PKD) and emphysema. The calcium-permeable cation channel protein polycystin 2 (PC2) is overexpressed in kidneys of TAZ-/- mice as a result of decreased degradation via an SCF(beta-Trcp) E3 ubiquitin ligase pathway. Replacements of serines in a phosphodegron motif in TAZ prevent beta-Trcp binding and PC2 degradation. Coexpression of a cytoplasmic fragment of polycystin 1 blocks the PC2-TAZ interaction and prevents TAZ-mediated degradation of PC2. Depletion of TAZ in zebrafish also results in a cystic kidney accompanied by overexpression of PC2. These results establish a common role of TAZ across vertebrate species in a protein degradation pathway regulated by phosphorylation and implicate deficiencies in this pathway in the development of PKD.
Insights
The transcriptional regulator TAZ binds beta-Trcp, impacting protein degradation. TAZ deficiency causes polycystic kidney disease (PKD) by increasing polycystin 2 (PC2) levels, revealing TAZ
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- The transcriptional regulator TAZ has known roles in gene expression.
- Polycystic kidney disease (PKD) is a genetic disorder characterized by kidney cyst formation.
- Protein degradation pathways, such as ubiquitination, are crucial for cellular homeostasis.
Purpose of the Study:
- To investigate the novel functions of the transcriptional regulator TAZ.
- To elucidate the molecular mechanisms underlying TAZ-deficient polycystic kidney disease (PKD).
- To explore the role of TAZ in protein degradation pathways.
Main Methods:
- Generation and analysis of TAZ knockout (TAZ-/-) mice.
- Investigation of polycystin 2 (PC2) expression and degradation in TAZ-/- kidneys.
- Biochemical assays to study TAZ-beta-Trcp binding and PC2-TAZ interactions.
- Functional studies in zebrafish models.
Main Results:
- TAZ knockout mice develop polycystic kidney disease (PKD) and emphysema.
- PC2 is overexpressed in TAZ-/- kidneys due to impaired degradation via the SCF(beta-Trcp) ubiquitin ligase pathway.
- Phosphorylation-dependent TAZ-beta-Trcp interaction regulates PC2 degradation; disruption prevents degradation.
- TAZ depletion in zebrafish also leads to cystic kidneys and PC2 overexpression.
Conclusions:
- TAZ functions as a binding partner for the F-box protein beta-Trcp, regulating protein degradation.
- Defects in the TAZ-mediated protein degradation pathway contribute to the pathogenesis of polycystic kidney disease (PKD).
- This pathway is conserved across vertebrate species.
More Related Videos
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Unfolded Protein Response
Export of Misfolded Proteins out of the ER
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

